Researchers
Srdić-Rajić, Tatjana
Results 21-40 of 180
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2023 | Nischarin expression may have differing roles in male and female melanoma patients | Ostojić, Marija   ; Jevrić, Marko ; Mitrović-Ajtić, Olivera ; Živić Kristina ; Tanić, Miljana ; Čavić, Milena ; Srdić-Rajić, Tatjana ; Grahovac, Jelena | Article | 21M21 |
| 2023 | Synthesis, characterization, and in vivo evaluation of the anticancer activity of a series of 5- and 6-(halomethyl)-2,2′-bipyridine rhenium tricarbonyl complexes | Nasiri Sovari, Sara; Kolly, Isabelle; Schindler, Kevin; Djurić, Ana ; Srdić-Rajić, Tatjana ; Crochet, Aurelien; Pavić, Aleksandar ; Zobi, Fabio | Article | 21aM21a |
| 2023 | Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma | Nemanja Djokovic ; Ana Djuric ; Dusan Ruzic ; Tatjana Srdic-Rajic ; Katarina Nikolic | Article | 21M21 |
| 2023 | Antiproliferative effect of tubastatin A on vemurafenib sensitive and resistant A375 melanoma cells | Vuletić, Ana ; Đinović, Vuk; Miletić, Nevena Tišma ; Srdić-Rajić, Tatjana ; Martinović, Mirjačić Katarina | Conference Paper | Mp. category will be shown later |
| 2023 | Towards the multitarget HDAC Inhibitors for the treatment of pancreatic carcinoma by joining the drug synergy predictions and the molecular modeling | Đoković, Nemanja ; Ilić, Aleksandra ; Čebzan, Alen ; Radović, Branko ; Ružić, Dušan ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Cationic amphiphilic drugs as potential anticancer therapy for PDAC | Živanović, Marija ; Selaković, Milica ; Selaković, Života ; Pavić, Aleksandar ; Grahovac, Jelena ; Šolaja, Bogdan ; Srdić-Rajić, Tatjana | Conference Paper | Mp. category will be shown later |
| 2022 | Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasion | Pavlovic, Marijana ; Ostojic, Marija Z ; Zivic, Kristina ; Pavic, Aleksandar B ; Srdic-Rajic, Tatjana V ; Grahovac, Jelena S | Conference Paper | Mp. category will be shown later |
| 2022 | Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients | Martinovic, Mirjacic Katarina ; Vuletić, Ana ; Mališić, Emina ; Rajić, Tatjana Srdić- ; Miletić, Nevena Tišma ; Babović, Nada ; Jurišić, Vladimir | Article | 22M22 |
| 2022 | Nischarin receptor agonist rilmenidine decreases production of pro-tumorigenic cytokines and growth factors in pancreatic ductal adenocarcinoma stellate cells | Živić, Kristina ; Ostojić, Marija ; Pavlović, Marijana ; Srdić-Rajić, Tatjana ; Danijel Galun ; Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2022 | Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention | Ružić, Dušan ; Đoković, Nemanja ; Srdić-Rajić, Tatjana ; Echeverria, Cesar; Nikolić, Katarina ; Santibanez, Juan | Article | 21aM21a |
| 2022 | Epigenetic drug discovery: fragment-based drug design of novel 1-benzhydryl-piperazine derivatives as selective histone deacetylase 6 inhibitors | Ružić, Dušan ; Đoković, Nemanja ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation | Ružić, Dušan ; Ellinger, Bernhard; Đoković, Nemanja ; Santibanez, Juan ; Gul, Sheraz; Beljkaš, Milan ; Đurić, Ana ; Ganesan, Arasu; Pavić, Aleksandar ; Srdić-Rajić, Tatjana ;
Petković, Miloš
; Nikolić, Katarina ; | Article | 21aM21a |
| 2022 | Antibody VH domain sequence analysis by a bioinformatics approach based on electronic amino acid properties may help to predict paratop location | Srdić-Rajić, Tatjana ; Metlaš, Radmila | Article | 22M22 |
| 2022 | Rational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6 | Ružić, Dušan ; Đoković, Nemanja ; Petković, Miloš ; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics | Đoković, Nemanja ; Ružić, Dušan ; Rahnasto-Rilla, Mina; Srdić-Rajić, Tatjana ; Lahtela-Kakkonen, Maija; Nikolić, Katarina | Article | 21aM21a |
| 2022 | Rilmenidine binds to and inhibits the activity of MDR pumps in pancreatic ductal adenocarcinoma | Ostojić, Marija ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Dobričić, Vladimir ; Grahovac, Jelena | Conference Paper | Mp. category will be shown later |
| 2022 | The Effects of Resveratrol-Rich Extracts of Vitis vinifera Pruning Waste on HeLa, MCF-7 and MRC-5 Cells: Apoptosis, Autophagia and Necrosis Interplay | Jovanović Galović, Aleksandra ; Jovanović Lješković, Nataša ; Vidović, Senka ; Vladić, Jelena ; Jojić, Nikola ; Ilić, Milan ; Srdić Rajić, Tatjana ; Kojić, Vesna ; Jakimov, Dimitar | Article | 21aM21a |
| 2022 | Evaluation of the anticancer activity of disulfiram in breast cancer | Ivana Srbljak Ćuk ; Đurić, Ana ; Rajić, Srdić Tatjana | Conference Paper | Mp. category will be shown later |
| 2022 | Novel protocol for enhanced sampling of binding pocket dynamics and its integration into the sirtuin 2 inhibitors virtual screening campaign | Đoković, Nemanja ; Ružić, Dušan ; Rahnasto‐Rilla, Minna; Srdić-Rajić, Tatjana ; Lahtela‐Kakkonen, Maija; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Identification of novel 1-benzhydryl-piperazine derivatives as Histone Deacetylase inhibitors using Fragment-based drug design strategy | Ružić, Dušan ; Ellinger, Bernhard; Đoković, Nemanja ; Santibanez, Juan ; Ganesan, A.; Pavić, Aleksandar; Srdić Rajić, Tatjana ; Petković, Miloš ; Nikolić, Katarina | Other | Mp. category will be shown later |